TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households
Brief Summary: This study will test the effectiveness of face masks and hand cleaning in preventing the spread of influenza within households


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Alcohol-based hand sanitizer & quaternary ammonium wipes | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alcohol-based hand sanitizer & quaternary ammonium wipes; Assigned to Arm(s): 1
B: Arm Label: Vitamin D and gargling; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol (vitamin D3), Behavioral: Gargling | Arm Label: Vitamin D and general health advice; Type: EXPERIMENTAL; Interventions: Dietary Supplement: cholecalciferol (vitamin D3) | Arm Label: Placebo and general health advice; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Placebo and gargling; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Gargling, Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol (vitamin D3); Assigned to Arm(s): Vitamin D and gargling, Vitamin D and general health advice | Intervention Type: BEHAVIORAL; Name: Gargling; Assigned to Arm(s): Placebo and gargling, Vitamin D and gargling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo and gargling, Placebo and general health advice
C: Intervention Type: PROCEDURE; Name: Laparotomy+ HIPEC +/- CRS; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: health education | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene, Device: face masks | Intervention Type: BEHAVIORAL; Name: hand hygiene; Assigned to Arm(s): 2, 3 | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: face masks; Assigned to Arm(s): 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households
Brief Summary: This study will test the effectiveness of face masks and hand cleaning in preventing the spread of influenza within households


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: health education | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene, Device: face masks | Intervention Type: BEHAVIORAL; Name: hand hygiene; Assigned to Arm(s): 2, 3 | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: face masks; Assigned to Arm(s): 3
B: Intervention Type: DRUG; Name: amantadine hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: oseltamivir phosphate; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Pardaprunox | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: pramipexole | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Comparator | Intervention Type: DRUG; Name: Pardaprunox; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: pramipexole; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo Comparator; Assigned to Arm(s): 3
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: pardoprunox | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Pardoprunox | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Pardoprunox | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: pardoprunox; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Pardoprunox; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Pardoprunox; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 4

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households
Brief Summary: This study will test the effectiveness of face masks and hand cleaning in preventing the spread of influenza within households


Options:
A: Arm Label: Hand washing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hand washing | Arm Label: Disinfectant rubbing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Disinfectant rubbing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Hand washing; Assigned to Arm(s): Hand washing | Intervention Type: BEHAVIORAL; Name: Disinfectant rubbing; Assigned to Arm(s): Disinfectant rubbing
B: Arm Label: 1. Surgical; Type: ACTIVE_COMPARATOR; Interventions: Device: Surgical mask | Arm Label: 2. N95 Respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 mask | Intervention Type: DEVICE; Name: Surgical mask; Assigned to Arm(s): 1. Surgical | Intervention Type: DEVICE; Name: N95 mask; Assigned to Arm(s): 2. N95 Respirator
C: Arm Label: Facemask and hand hygiene; Type: EXPERIMENTAL; Interventions: Behavioral: Ear Loop Procedure Mask, Behavioral: 62% Ethyl Alcohol Hand Sanitizer | Arm Label: Facemask only; Type: EXPERIMENTAL; Interventions: Behavioral: Ear Loop Procedure Mask | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Ear Loop Procedure Mask; Assigned to Arm(s): Facemask and hand hygiene, Facemask only | Intervention Type: BEHAVIORAL; Name: 62% Ethyl Alcohol Hand Sanitizer; Assigned to Arm(s): Facemask and hand hygiene
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: health education | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene, Device: face masks | Intervention Type: BEHAVIORAL; Name: hand hygiene; Assigned to Arm(s): 2, 3 | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: face masks; Assigned to Arm(s): 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households
Brief Summary: This study will test the effectiveness of face masks and hand cleaning in preventing the spread of influenza within households


Options:
A: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Concert, Diagnostic Test: Rapid nasopharyngeal antigen test for Sars-Cov-2, Diagnostic Test: Saliva Sample | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Diagnostic Test: Rapid nasopharyngeal antigen test for Sars-Cov-2, Diagnostic Test: Saliva Sample | Intervention Type: OTHER; Name: Concert; Assigned to Arm(s): Experimental | Intervention Type: DIAGNOSTIC_TEST; Name: Rapid nasopharyngeal antigen test for Sars-Cov-2; Assigned to Arm(s): Control, Experimental | Intervention Type: DIAGNOSTIC_TEST; Name: Saliva Sample; Assigned to Arm(s): Control, Experimental
B: Arm Label: Hand washing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hand washing | Arm Label: Disinfectant rubbing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Disinfectant rubbing | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Hand washing; Assigned to Arm(s): Hand washing | Intervention Type: BEHAVIORAL; Name: Disinfectant rubbing; Assigned to Arm(s): Disinfectant rubbing
C: Arm Label: Green tea; Type: EXPERIMENTAL; Interventions: Dietary Supplement: green tea | Arm Label: water; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: green tea | Intervention Type: DIETARY_SUPPLEMENT; Name: green tea; Assigned to Arm(s): Green tea, water
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: health education | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene, Device: face masks | Intervention Type: BEHAVIORAL; Name: hand hygiene; Assigned to Arm(s): 2, 3 | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: face masks; Assigned to Arm(s): 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cardiovascular Effects of Pine Bark Extract
Brief Summary: The purpose of this study is to investigate the efficacy of Flavangenol® (Toyo Shinyaku, Japan), a pine bark extract, in lowering blood pressure and improving glycemic control and plasma lipoprotein profile.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Pine Bark Extract (Flavangenol®) | Arm Label: Pine Bark Extract; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pine Bark Extract (Flavangenol®) | Intervention Type: DRUG; Name: Pine Bark Extract (Flavangenol®); Assigned to Arm(s): Pine Bark Extract, Placebo
B: Arm Label: supplement - no retinopathy; Type: EXPERIMENTAL; Interventions: Dietary Supplement: multi-component nutritional supplement capsules | Arm Label: placebo - no retinopathy; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: multi-component dietary supplement | Arm Label: supplement - retinopathy; Type: EXPERIMENTAL; Interventions: Dietary Supplement: multi-component nutritional supplement capsules | Arm Label: placebo - retinopathy; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: multi-component dietary supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: multi-component nutritional supplement capsules; Assigned to Arm(s): supplement - no retinopathy, supplement - retinopathy | Intervention Type: DIETARY_SUPPLEMENT; Name: multi-component dietary supplement; Assigned to Arm(s): placebo - no retinopathy, placebo - retinopathy
C: Arm Label: Pycnogenol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Pycnogenol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Methylphenidate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate | Intervention Type: DIETARY_SUPPLEMENT; Name: Pycnogenol; Assigned to Arm(s): Pycnogenol | Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): Methylphenidate | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Pycnogenol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pycnogenol | Intervention Type: DRUG; Name: Pycnogenol; Assigned to Arm(s): Pycnogenol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Male Circumcision for HIV Prevention, Rakai, Uganda
Brief Summary: Circumcision in HIV unifected men may reduce the likelihood of becoming infected with HIV, reduce sexually transmitted infections (STIs) in men, not engender increases in sexual risk behaviors, and be acceptable to men as a procedure for preventing HIV. The purpose of this study is to evaluate circumcision in HIV uninfected men in terms of safety and ability to prevent HIV infection.


Options:
A: Arm Label: Acyclovir; Type: ACTIVE_COMPARATOR; Interventions: Drug: Generic acyclovir | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Generic acyclovir; Assigned to Arm(s): Acyclovir | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Standard dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: valacyclovir | Arm Label: High-dose; Type: EXPERIMENTAL; Interventions: Drug: acyclovir | Intervention Type: DRUG; Name: acyclovir; Assigned to Arm(s): High-dose | Intervention Type: DRUG; Name: valacyclovir; Assigned to Arm(s): Standard dose
C: Intervention Type: PROCEDURE; Name: Adult male circumcision; Assigned to Arm(s): N/A
D: Arm Label: Arm 1 Male circumcision; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Male circumcision | Arm Label: Arm 2; Type: NO_INTERVENTION; Interventions: Procedure: Male circumcision | Intervention Type: PROCEDURE; Name: Male circumcision; Assigned to Arm(s): Arm 1 Male circumcision, Arm 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Male Circumcision for HIV Prevention, Rakai, Uganda
Brief Summary: Circumcision in HIV unifected men may reduce the likelihood of becoming infected with HIV, reduce sexually transmitted infections (STIs) in men, not engender increases in sexual risk behaviors, and be acceptable to men as a procedure for preventing HIV. The purpose of this study is to evaluate circumcision in HIV uninfected men in terms of safety and ability to prevent HIV infection.


Options:
A: Arm Label: Circumcised immediately; Type: ACTIVE_COMPARATOR; Interventions: Procedure: male circumcision | Arm Label: Delayed Circumcision; Type: PLACEBO_COMPARATOR; Interventions: Procedure: male circumcision | Intervention Type: PROCEDURE; Name: male circumcision; Assigned to Arm(s): Circumcised immediately, Delayed Circumcision
B: Intervention Type: PROCEDURE; Name: Male Circumcision; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Stepping Stones | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: stepping Stones short | Intervention Type: BEHAVIORAL; Name: Stepping Stones; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: stepping Stones short; Assigned to Arm(s): 2
D: Intervention Type: PROCEDURE; Name: Adult male circumcision; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Male Circumcision for HIV Prevention, Rakai, Uganda
Brief Summary: Circumcision in HIV unifected men may reduce the likelihood of becoming infected with HIV, reduce sexually transmitted infections (STIs) in men, not engender increases in sexual risk behaviors, and be acceptable to men as a procedure for preventing HIV. The purpose of this study is to evaluate circumcision in HIV uninfected men in terms of safety and ability to prevent HIV infection.


Options:
A: Arm Label: Unicirc with tissue adhesive; Type: EXPERIMENTAL; Interventions: Procedure: Unicirc with tissue adhesive | Arm Label: Open Surgical; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Surgical | Intervention Type: PROCEDURE; Name: Unicirc with tissue adhesive; Assigned to Arm(s): Unicirc with tissue adhesive | Intervention Type: PROCEDURE; Name: Open Surgical; Assigned to Arm(s): Open Surgical
B: Arm Label: PrePex™ device; Type: EXPERIMENTAL; Interventions: Device: PrePex™ device for adult male circumcision | Arm Label: Surgical; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgical circumcision | Intervention Type: DEVICE; Name: PrePex™ device for adult male circumcision; Assigned to Arm(s): PrePex™ device | Intervention Type: PROCEDURE; Name: Surgical circumcision; Assigned to Arm(s): Surgical
C: Intervention Type: PROCEDURE; Name: Adult male circumcision; Assigned to Arm(s): N/A
D: Arm Label: Circumcised immediately; Type: ACTIVE_COMPARATOR; Interventions: Procedure: male circumcision | Arm Label: Delayed Circumcision; Type: PLACEBO_COMPARATOR; Interventions: Procedure: male circumcision | Intervention Type: PROCEDURE; Name: male circumcision; Assigned to Arm(s): Circumcised immediately, Delayed Circumcision

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Prospective controlled randomized clinical trial. Consecutive patients with acute proximal deep vein thrombosis of the lower extremities, with or without contemporary manifestations of pulmonary embolism, are randomized to receive either a below-knee or a full-leg graduated compression (30-40 mm Hg at the ankle) elastic stocking for prevention of the post-thrombotic syndrome (PTS). All patients are followed up to three years to assess the development of the PTS, defined according to a validated clinical score (the Villalta scale). The rate of PTS is compared between the two study groups. In addition, there is an assessment of patients' compliance and tolerability of the two different devices.


Options:
A: Arm Label: Intervention: individually tailored ECS; Type: EXPERIMENTAL; Interventions: Device: Individually tailored duration of elastic compression therapy | Arm Label: Control: ECS 24 months; Type: ACTIVE_COMPARATOR; Interventions: Device: Elastic compression therapy with a standard duration of 24 months | Intervention Type: DEVICE; Name: Individually tailored duration of elastic compression therapy; Assigned to Arm(s): Intervention: individually tailored ECS | Intervention Type: DEVICE; Name: Elastic compression therapy with a standard duration of 24 months; Assigned to Arm(s): Control: ECS 24 months
B: Arm Label: I; Type: EXPERIMENTAL; Interventions: Procedure: catheter-directed venous thrombolysis | Arm Label: II; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: catheter-directed venous thrombolysis; Assigned to Arm(s): I
C: Intervention Type: DEVICE; Name: Elastic stockings; Assigned to Arm(s): N/A
D: Arm Label: A-Intervention; Type: EXPERIMENTAL; Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA) | Arm Label: B-Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Recombinant tissue plasminogen activator (rt-PA); Assigned to Arm(s): A-Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double Blinded, Randomized Trial of Swallowed 1760mcg Fluticasone Propionate Versus Placebo in the Treatment of Eosinophilic Esophagitis
Brief Summary: The purpose of this study is to test the effects (both good and bad) of high dose swallowed fluticasone propionate (Flovent) in subjects with eosinophilic esophagitis (EoE).


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: esomeprazole | Intervention Type: DRUG; Name: esomeprazole; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: fluticasone; Assigned to Arm(s): 1
B: Arm Label: Flovent 1760 mcg; Type: EXPERIMENTAL; Interventions: Drug: Flovent | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Flovent; Assigned to Arm(s): Flovent 1760 mcg | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: omalizumab; Type: EXPERIMENTAL; Interventions: Drug: omalizumab | Intervention Type: DRUG; Name: omalizumab; Assigned to Arm(s): omalizumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
D: Arm Label: Arms A OBS Completers/ Responders; Type: EXPERIMENTAL; Interventions: Drug: Oral Budesonide Suspension (OBS) | Arm Label: Arm B OBS Completers/ Responders; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Arm C OBS Completers/ Non-Responders; Type: EXPERIMENTAL; Interventions: Drug: Oral Budesonide Suspension (OBS) | Arm Label: Arm D Placebo Completers; Type: EXPERIMENTAL; Interventions: Drug: Oral Budesonide Suspension (OBS) | Intervention Type: DRUG; Name: Oral Budesonide Suspension (OBS); Assigned to Arm(s): Arm C OBS Completers/ Non-Responders, Arm D Placebo Completers, Arms A OBS Completers/ Responders | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm B OBS Completers/ Responders

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomized, Controlled, Double Blinded Trial of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Brief Summary: a statement of the study hypothesis:the effect of valsartan in patients with IgA nephropathy have been proved,and the efficacy of probucol in combination with valsartan is to be proved in patients with IgA nephropathy.

This is a prospective randomized controlled, double blinded pilot study to identify the efficacy of probucol in combination with valsartan in patients with IgA nephropathy. The renal function deterioration will be the primary outcome studied. The expected study duration will be 36 months.


Options:
A: Arm Label: sparsentan; Type: EXPERIMENTAL; Interventions: Drug: sparsentan | Arm Label: irbesartan; Type: ACTIVE_COMPARATOR; Interventions: Drug: irbesartan | Arm Label: dapagliflozin + sparsentan (Sub study); Type: EXPERIMENTAL; Interventions: Drug: sparsentan, Drug: Dapagliflozin | Arm Label: sparsentan (Sub Study); Type: EXPERIMENTAL; Interventions: Drug: sparsentan | Intervention Type: DRUG; Name: sparsentan; Assigned to Arm(s): dapagliflozin + sparsentan (Sub study), sparsentan, sparsentan (Sub Study) | Intervention Type: DRUG; Name: irbesartan; Assigned to Arm(s): irbesartan | Intervention Type: DRUG; Name: Dapagliflozin; Assigned to Arm(s): dapagliflozin + sparsentan (Sub study)
B: Arm Label: Hydroxychloroquine Sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydroxychloroquine Sulfate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydroxychloroquine Sulfate; Assigned to Arm(s): Hydroxychloroquine Sulfate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: prednisone + Inhibace/Cozaar; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Inhibace/Cozaar; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Valsartan, Drug: Placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Valsartan, Drug: Probucol | Intervention Type: DRUG; Name: Valsartan; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Probucol; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 1

Answer: D